Standout Papers

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4 2019 2026 2021 2023 818
  1. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4 (2019)
    Shuang Qin, Linping Xu et al. Molecular Cancer
  2. Regulation of PD-L1 expression in the tumor microenvironment (2021)
    Ming Yi, Mengke Niu et al. Journal of Hematology & Oncology

Immediate Impact

3 by Nobel laureates 2 from Science/Nature 52 standout
Sub-graph 1 of 22

Citing Papers

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Succinate Nanomaterials Boost Tumor Immunotherapy via Activating Cell Pyroptosis and Enhancing MHC-I Expression
2025 Standout
1 intermediate paper

Works of Linping Xu being referenced

The role of cancer-derived microRNAs in cancer immune escape
2020
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
2019 Standout

Author Peers

Author Last Decade Papers Cites
Linping Xu 723 1144 779 52 2.1k
Hazem Ghebeh 722 1711 934 48 2.6k
Yuping Sun 790 1293 802 80 2.3k
Anna E. Vilgelm 758 1021 612 47 1.8k
Tomonori Yaguchi 663 968 890 69 2.0k
Carsten Weishaupt 931 1324 850 59 2.6k
Yong Lu 907 974 1236 54 2.4k
Afshin Derakhshani 724 775 624 67 1.8k
Jay Friedman 824 1199 1023 54 2.5k
Kiyoshi Yoshimura 685 1178 1201 84 2.4k
Nicholas Borcherding 1223 885 720 76 2.5k

All Works

Loading papers...

Rankless by CCL
2026